文献速递胸部肿瘤放疗放疗物理与技术

基于CT的新型客观影像生物标志物用于量化长期放射性肺损伤

Novel CT-Based Objective Imaging Biomarkers of Long-Term Radiation-Induced Lung Damage.
PubMed 文献 · Int J Radiat Oncol Biol Phys · 2018-09-11

本研究基于27例接受同毒性放化疗的1/2期临床试验患者的基线与12个月CT扫描,开发了12项定量影像生物标志物以描述肺实质改变、体积缩小和胸膜改变。多数标志物可测量且能客观评分严重程度;除主支气管旋转和膈肌曲度外,各标志物在视觉评估有无两组间均有统计学显著差异。多数标志物间相关性不强,提示各自测量放射性肺损伤的不同病理要素。

要点

  • 开发了12项基于CT的定量影像生物标志物,用于量化放疗后12个月放射性肺损伤。
  • 多数标志物在每例患者中可测量,可对严重程度进行客观连续评分。
  • 除主支气管旋转和膈肌曲度外,各标志物在视觉评估有无两组间均有统计学显著差异。

核心结论

  • 作者开发了基于CT的客观影像生物标志物,可量化放疗后放射性肺损伤的严重程度,这些标志物代表了放射性肺损伤的典型影像学表现。

研究设计与样本

  • 研究纳入27例来自同毒性放化疗1/2期临床试验患者的基线与12个月CT扫描,开发了12项定量影像生物标志物并以半自动图像分析流程实现,与视觉评估各改变是否发生进行对照。

主要发现

  • 多数生物标志物在每例患者中可测量,其连续性质允许对每例患者进行客观严重程度评分。
  • 按视觉评估各生物标志物有无将队列分为两组后,除主支气管旋转和膈肌曲度外,所有特征在两组间均有统计学显著差异。
  • 多数生物标志物之间相关性不强,提示各标志物测量的是放射性肺损伤病理的不同要素。

关键数值与推荐

  • 共开发12项定量影像生物标志物,描述肺实质改变、体积缩小和胸膜改变等基本CT表现。
  • 除主支气管旋转和膈肌曲度外,各影像生物标志物在视觉评估有无两组间均有统计学显著差异。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Recent improvements in lung cancer survival have spurred an interest in understanding and minimizing long-term radiation-induced lung damage (RILD). However, there are still no objective criteria to quantify RILD, leading to variable reporting across centers and trials. We propose a set of objective imaging biomarkers for quantifying common radiologic findings observed 12 months after lung cancer radiation therapy. METHODS AND MATERIALS: Baseline and 12-month computed tomography (CT) scans of 27 patients from a phase 1/2 clinical trial of isotoxic chemoradiation were included in this study. To detect and measure the severity of RILD, 12 quantitative imaging biomarkers were developed. The biomarkers describe basic CT findings, including parenchymal change, volume reduction, and pleural change. The imaging biomarkers were implemented as semiautomated image analysis pipelines and were assessed against visual assessment of the occurrence of each change. RESULTS: Most of the biomarkers were measurable in each patient. The continuous nature of the biomarkers allows objective scoring of severity for each patient. For each imaging biomarker, the cohort was split into 2 groups according to the presence or absence of the biomarker by visual assessment, testing the hypothesis that the imaging biomarkers were different in the 2 groups. All features were statistically significant except for rotation of the main bronchus and diaphragmatic curvature. Most of the biomarkers were not strongly correlated with each other, suggesting that each of the biomarkers is measuring a separate element of RILD pathology. CONCLUSIONS: We developed objective CT-based imaging biomarkers that quantify the severity of radiologic lung damage after radiation therapy. These biomarkers are representative of typical radiologic findings of RILD.

来源:Int J Radiat Oncol Biol Phys,查看原文。版权归原作者所有。

引用

  1. Veiga C, Landau D, Devaraj A, et al. Novel CT-Based Objective Imaging Biomarkers of Long-Term Radiation-Induced Lung Damage. Int J Radiat Oncol Biol Phys. 2018. PMID: 29908943. doi:10.1016/j.ijrobp.2018.06.006

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。